NATCO PHARMA LTD. - 524816 - Reg 7(3) Compliance Certificate
Reg 7(3) compliance Certificate05-04-2024
05-04-2024
NATCO PHARMA LTD. - 524816 - Reg 40(10) PCS Certificate For The Half Year Ending March 31, 2024
Reg 40(10) PCS certificate for the half year ending March 31, 202405-04-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate04-04-2024
NATCO PHARMA LTD. - 524816 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
E-voting Results along with Scrutinizers Report of Postal Ballot Notice dated February 14, 202427-03-2024
Accumulate NATCO Pharma; target of Rs 1116: Geojit Financial Services
Geojit Financial Services recommended accumulate rating on NATCO Pharma with a target price of Rs 1116 in its research report dated March 27, 2024.27-03-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificate12-03-2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet on 6th March, 202402-03-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share Certificate01-03-2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Change in Management
Resignation & Appointment of Senior Management Personnel29-02-2024